Literature DB >> 1517779

Conformational studies on (+)-anatoxin-a and derivatives.

P E Thompson1, D T Manallack, F E Blaney, T Gallagher.   

Abstract

Anatoxin-a (AnTX) is a highly potent agonist acting at the nicotinic acetylcholine receptor (nAChR) and represents a valuable tool in the study of this receptor. Molecular mechanics, semi-empirical and ab initio molecular orbital energy minimization procedures were conducted to investigate the conformation of AnTX. For each minimization procedure, the s-trans enone isomer of protonated AnTX was the energetically favoured conformer due to intramolecular electrostatic interactions. Our studies are discussed in the light of previous experimental observations and conformational studies, in addition to their importance in the development of future pharmacophore models for nAChR agonist binding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517779     DOI: 10.1007/bf00123382

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  22 in total

1.  Letter: A revised structure for the antibiotic pillaromycin A.

Authors:  J O Pezzanite; J Clardy; P Y Lau; G Wood; D L Walker; B Fraser-Reid
Journal:  J Am Chem Soc       Date:  1975-10-15       Impact factor: 15.419

2.  Modeling of agonist binding to the ligand-gated ion channel superfamily of receptors.

Authors:  V B Cockcroft; D J Osguthorpe; E A Barnard; G G Lunt
Journal:  Proteins       Date:  1990

3.  Stereoselectivity of nicotinic receptors.

Authors:  U Hacksell; C Mellin
Journal:  Prog Brain Res       Date:  1989       Impact factor: 2.453

4.  Conformation of acetylcholine bound to the nicotinic acetylcholine receptor.

Authors:  R W Behling; T Yamane; G Navon; L W Jelinski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Structural and electronic requirements for potent agonists at a nicotinic receptor.

Authors:  C E Spivak; T M Gund; R F Liang; J A Waters
Journal:  Eur J Pharmacol       Date:  1986-01-14       Impact factor: 4.432

6.  A common structural model for central nervous system drugs and their receptors.

Authors:  E J Lloyd; P R Andrews
Journal:  J Med Chem       Date:  1986-04       Impact factor: 7.446

7.  Activation and blockade of the acetylcholine receptor-ion channel by the agonists (+)-anatoxin-a, the N-methyl derivative and the enantiomer.

Authors:  P Kofuji; Y Aracava; K L Swanson; R S Aronstam; H Rapoport; E X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

8.  Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor.

Authors:  A C Costa; K L Swanson; Y Aracava; R S Aronstam; E X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

9.  Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds.

Authors:  R B Barlow; O Johnson
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

10.  Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.

Authors:  K L Swanson; C N Allen; R S Aronstam; H Rapoport; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1986-03       Impact factor: 4.436

View more
  3 in total

1.  Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.

Authors:  O Nicolotti; M Pellegrini-Calace; A Carrieri; C Altomare; N B Centeno; F Sanz; A Carotti
Journal:  J Comput Aided Mol Des       Date:  2001-09       Impact factor: 3.686

2.  Drug design for ever, from hype to hope.

Authors:  G Seddon; V Lounnas; R McGuire; T van den Bergh; R P Bywater; L Oliveira; G Vriend
Journal:  J Comput Aided Mol Des       Date:  2012-01-18       Impact factor: 3.686

3.  Delineating the activity of the potent nicotinic acetylcholine receptor agonists (+)-anatoxin-a and (-)-hosieine-A.

Authors:  Holly P Parker; Alice Dawson; Mathew J Jones; Rui Yan; Jie Ouyang; Ran Hong; William N Hunter
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-08-09       Impact factor: 1.072

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.